HELIX BIOPHARMA (Germany) Probability of Future Stock Price Finishing Over 0.23

HBP Stock  EUR 1.15  0.00  0.00%   
HELIX BIOPHARMA's future price is the expected price of HELIX BIOPHARMA instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of HELIX BIOPHARMA performance during a given time horizon utilizing its historical volatility. Check out HELIX BIOPHARMA Backtesting, HELIX BIOPHARMA Valuation, HELIX BIOPHARMA Correlation, HELIX BIOPHARMA Hype Analysis, HELIX BIOPHARMA Volatility, HELIX BIOPHARMA History as well as HELIX BIOPHARMA Performance.
  
Please specify HELIX BIOPHARMA's target price for which you would like HELIX BIOPHARMA odds to be computed.

HELIX BIOPHARMA Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HELIX BIOPHARMA for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HELIX BIOPHARMA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
HELIX BIOPHARMA generated a negative expected return over the last 90 days
HELIX BIOPHARMA may become a speculative penny stock
HELIX BIOPHARMA has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (6.56 M) with profit before overhead, payroll, taxes, and interest of 0.
HELIX BIOPHARMA generates negative cash flow from operations

HELIX BIOPHARMA Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of HELIX Stock often depends not only on the future outlook of the current and potential HELIX BIOPHARMA's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HELIX BIOPHARMA's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding171.8 M
Short Long Term Debt2.5 M

HELIX BIOPHARMA Technical Analysis

HELIX BIOPHARMA's future price can be derived by breaking down and analyzing its technical indicators over time. HELIX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of HELIX BIOPHARMA. In general, you should focus on analyzing HELIX Stock price patterns and their correlations with different microeconomic environments and drivers.

HELIX BIOPHARMA Predictive Forecast Models

HELIX BIOPHARMA's time-series forecasting models is one of many HELIX BIOPHARMA's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary HELIX BIOPHARMA's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about HELIX BIOPHARMA

Checking the ongoing alerts about HELIX BIOPHARMA for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for HELIX BIOPHARMA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
HELIX BIOPHARMA generated a negative expected return over the last 90 days
HELIX BIOPHARMA may become a speculative penny stock
HELIX BIOPHARMA has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (6.56 M) with profit before overhead, payroll, taxes, and interest of 0.
HELIX BIOPHARMA generates negative cash flow from operations

Additional Tools for HELIX Stock Analysis

When running HELIX BIOPHARMA's price analysis, check to measure HELIX BIOPHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HELIX BIOPHARMA is operating at the current time. Most of HELIX BIOPHARMA's value examination focuses on studying past and present price action to predict the probability of HELIX BIOPHARMA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HELIX BIOPHARMA's price. Additionally, you may evaluate how the addition of HELIX BIOPHARMA to your portfolios can decrease your overall portfolio volatility.